MYELOID TARGETING PLATFORM
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98086316
- Registration number
- 7591913
- Mark type
- Stylized text
- Filed
- 14 Jul 2023
- Registered
- 03 Dec 2024
- Attorney of record
- Boris Umansky
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical research services in the field of cancer; scientific research; medical research; medical and scientific research in the field of drug discovery; pharmaceutical research services; medical and scientific research information in the field of drug discovery; DNA screening for scientific research purposes; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; cell culture services for scientific and research purposes, for others; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; DNA analysis services for scientific research purposes; scientific research consulting
Owner
- UNITED IMMUNITY, CO., LTD., Tokyo, JP
- UNITED IMMUNITY, CO., LTD., Tokyo, JP
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 12 Nov 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 12 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 12 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN
- 11 Oct 2024 — USE AMENDMENT ACCEPTED
- 09 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2024 — ASSIGNED TO LIE
- 24 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Jun 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 24 Jun 2024 — USE AMENDMENT FILED
- 24 Jun 2024 — TEAS AMENDMENT OF USE RECEIVED